IRIS Accounts Production v26.1.10.61 SC310515 Board of Directors 1.3.25 31.12.25 31.12.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC3105152025-02-28SC3105152025-12-31SC3105152025-03-012025-12-31SC3105152024-02-28SC3105152024-02-292025-02-28SC3105152025-02-28SC310515ns15:Scotland2025-03-012025-12-31SC310515ns14:PoundSterling2025-03-012025-12-31SC310515ns10:Director12025-03-012025-12-31SC310515ns10:PrivateLimitedCompanyLtd2025-03-012025-12-31SC310515ns10:SmallEntities2025-03-012025-12-31SC310515ns10:AuditExempt-NoAccountantsReport2025-03-012025-12-31SC310515ns10:SmallCompaniesRegimeForDirectorsReport2025-03-012025-12-31SC310515ns10:SmallCompaniesRegimeForAccounts2025-03-012025-12-31SC310515ns10:FullAccounts2025-03-012025-12-31SC31051512025-03-012025-12-31SC310515ns10:Director22025-03-012025-12-31SC310515ns10:RegisteredOffice2025-03-012025-12-31SC310515ns5:CurrentFinancialInstruments2025-12-31SC310515ns5:CurrentFinancialInstruments2025-02-28SC310515ns5:ShareCapital2025-12-31SC310515ns5:ShareCapital2025-02-28SC310515ns5:RetainedEarningsAccumulatedLosses2025-12-31SC310515ns5:RetainedEarningsAccumulatedLosses2025-02-28SC310515ns5:IntangibleAssetsOtherThanGoodwill2025-03-012025-12-31SC310515ns5:LandBuildings2025-03-012025-12-31SC310515ns5:PlantMachinery2025-03-012025-12-31SC310515ns5:NetGoodwill2025-02-28SC310515ns5:NetGoodwill2025-12-31SC310515ns5:NetGoodwill2025-02-28SC310515ns5:LandBuildings2025-02-28SC310515ns5:PlantMachinery2025-02-28SC310515ns5:LandBuildings2025-12-31SC310515ns5:PlantMachinery2025-12-31SC310515ns5:LandBuildings2025-02-28SC310515ns5:PlantMachinery2025-02-28SC310515ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-31SC310515ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-28
REGISTERED NUMBER: SC310515 (Scotland)














FINANCIAL STATEMENTS

FOR THE PERIOD 1 MARCH 2025 TO 31 DECEMBER 2025

FOR

Lg Pharmacy Ltd.

Lg Pharmacy Ltd. (Registered number: SC310515)






CONTENTS OF THE FINANCIAL STATEMENTS
For The Period 1 March 2025 to 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Lg Pharmacy Ltd.

COMPANY INFORMATION
For The Period 1 March 2025 to 31 December 2025







DIRECTORS: G Ali
A Ramzan





REGISTERED OFFICE: 476 St. Vincent Street
Glasgow
G3 8XU





REGISTERED NUMBER: SC310515 (Scotland)





ACCOUNTANTS: Burgoyne Carey
Chartered Accountants
Pavilion 2
3 Dava Street
Broomloan Road
Glasgow
G51 2JA

Lg Pharmacy Ltd. (Registered number: SC310515)

BALANCE SHEET
31 December 2025

2025 2025
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 239,295 81,815
239,295 81,815

CURRENT ASSETS
Stocks 65,000 68,925
Debtors 6 197,388 213,564
Cash at bank and in hand 443,687 176,120
706,075 458,609
CREDITORS
Amounts falling due within one year 7 (472,080 ) (234,488 )
NET CURRENT ASSETS 233,995 224,121
TOTAL ASSETS LESS CURRENT
LIABILITIES

473,290

305,936

PROVISIONS FOR LIABILITIES (23,074 ) (15,545 )
NET ASSETS 450,216 290,391

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 449,216 289,391
450,216 290,391

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lg Pharmacy Ltd. (Registered number: SC310515)

BALANCE SHEET - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 July 2026 and were signed on its behalf by:





G Ali - Director


Lg Pharmacy Ltd. (Registered number: SC310515)

NOTES TO THE FINANCIAL STATEMENTS
For The Period 1 March 2025 to 31 December 2025

1. STATUTORY INFORMATION

Lg Pharmacy Ltd. is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover represents amounts invoiced during the year net, exclusive of Value Added Tax.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost
Plant and machinery etc - 25% on reducing balance and 20% on reducing balance

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company offers a defined contribution pension scheme to employees. Contributions payable to the pension scheme are charged to profit or loss in the period to which they relate.

Lg Pharmacy Ltd. (Registered number: SC310515)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Period 1 March 2025 to 31 December 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 8 (2025 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 March 2025
and 31 December 2025 453,680
AMORTISATION
At 1 March 2025
and 31 December 2025 453,680
NET BOOK VALUE
At 31 December 2025 -
At 28 February 2025 -

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 March 2025 - 434,872 434,872
Additions 150,000 30,886 180,886
Disposals - (100,000 ) (100,000 )
At 31 December 2025 150,000 365,758 515,758
DEPRECIATION
At 1 March 2025 - 353,057 353,057
Charge for period 3,000 20,406 23,406
Eliminated on disposal - (100,000 ) (100,000 )
At 31 December 2025 3,000 273,463 276,463
NET BOOK VALUE
At 31 December 2025 147,000 92,295 239,295
At 28 February 2025 - 81,815 81,815

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2025
£    £   
Trade debtors 175,702 174,297
Other debtors 21,686 39,267
197,388 213,564

Lg Pharmacy Ltd. (Registered number: SC310515)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Period 1 March 2025 to 31 December 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2025
£    £   
Trade creditors 178,054 181,171
Amounts owed to associates 234,343 -
Taxation and social security 59,683 49,797
Other creditors - 3,520
472,080 234,488

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is BNC Healthcare Limited.